Congress Asset Management Co. MA Purchases 84,757 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Congress Asset Management Co. MA raised its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 12.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 764,013 shares of the company’s stock after purchasing an additional 84,757 shares during the period. Congress Asset Management Co. MA owned 1.54% of Prestige Consumer Healthcare worth $55,437,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of PBH. Deutsche Bank AG grew its holdings in Prestige Consumer Healthcare by 21.1% during the third quarter. Deutsche Bank AG now owns 27,940 shares of the company’s stock valued at $1,598,000 after purchasing an additional 4,867 shares during the period. Rhumbline Advisers grew its position in shares of Prestige Consumer Healthcare by 1.1% in the third quarter. Rhumbline Advisers now owns 173,818 shares of the company’s stock valued at $9,941,000 after purchasing an additional 1,951 shares in the last quarter. QRG Capital Management Inc. purchased a new position in shares of Prestige Consumer Healthcare in the third quarter valued at $306,000. Provence Wealth Management Group purchased a new position in shares of Prestige Consumer Healthcare in the third quarter valued at $26,000. Finally, Hsbc Holdings PLC grew its position in shares of Prestige Consumer Healthcare by 17.1% in the third quarter. Hsbc Holdings PLC now owns 22,075 shares of the company’s stock valued at $1,263,000 after purchasing an additional 3,226 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock traded up $4.12 during midday trading on Friday, hitting $69.40. 801,810 shares of the company’s stock were exchanged, compared to its average volume of 211,611. Prestige Consumer Healthcare Inc. has a 52-week low of $56.34 and a 52-week high of $75.31. The stock has a 50-day moving average price of $67.16 and a two-hundred day moving average price of $66.34. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.20. The company has a market cap of $3.46 billion, a P/E ratio of 16.64, a PEG ratio of 1.85 and a beta of 0.50.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.12). Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. The business had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $287.42 million. During the same quarter in the previous year, the firm earned $1.07 earnings per share. Prestige Consumer Healthcare’s quarterly revenue was down 3.1% compared to the same quarter last year. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on PBH. StockNews.com cut Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. DA Davidson upgraded Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and lifted their price target for the company from $65.00 to $93.00 in a research report on Friday. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $80.00 price target on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $98.25.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.